Skip to content

Lidocaine Irrigation in Shoulder Arthroscopy

Efficacy of Lidocaine Saline Irrigation in Patients Undergoing Shoulder Arthroscopy: Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05624957
Enrollment
50
Registered
2022-11-22
Start date
2022-11-25
Completion date
2023-08-01
Last updated
2023-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain, Analgesia

Keywords

Postoperative pain, Lidocaine, Shoulder arthroscopy

Brief summary

Arthroscopic shoulder surgery is often associated with severe postoperative pain that is often significant enough to interfere with initial recovery and rehabilitation. The pain that can be difficult to manage without large dose of opioid. The study aim to explore the effect of continuous irrigation of fluids mixed with lidocaine and epinephrine for analgesic consumption and postoperative pain after shoulder arthroscopy.

Interventions

Under aseptic condition every one litre of fluid irrigation will be mixture with 10 ml of lidocaine 2% and 0.25mg epinephrine and the last one use before end of surgery dexamethasone 8 mg will be added.

0.25 mg epinephrine mixed with one litre of fluid irrigation

Sponsors

Minia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 20-60 * Both genders * Shoulder arthroscopy * ASA I-III

Exclusion criteria

* Drug allergy * Psychiatric disorder * Opioid dependence * Liver disease * Patient refuse

Design outcomes

Primary

MeasureTime frameDescription
total analgesic consumption24 hourstotal nalbuphine consumed one day after surgery

Secondary

MeasureTime frameDescription
first analgesic request24 hourstime of PCA request
Visual analogue pain score24 hourspain intensity at rest and movement from 0-10 which 0 no pain and 10 the worst pain

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026